Shanghai Shyndec Pharmaceutical Co., Ltd. (SHA:600420)
China · Delayed Price · Currency is CNY 8.29
-0.07 (-0.84%)
Nov 6, 2026, 3:00 PM CST
SHA:600420 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 4,139 | 4,006 | 6,212 | 5,973 | 6,148 | 4,284 |
Short-Term Investments | - | 3,055 | 1,431 | - | - | - |
Cash & Short-Term Investments | 4,139 | 7,061 | 7,643 | 5,973 | 6,148 | 4,284 |
Cash Growth | -0.05% | -7.61% | 27.97% | -2.86% | 43.51% | 15.18% |
Accounts Receivable | 1,540 | 1,167 | 1,361 | 2,051 | 2,656 | 3,048 |
Other Receivables | 83.98 | 81.55 | 85.55 | 84.07 | 92.85 | 96.91 |
Receivables | 1,624 | 1,248 | 1,447 | 2,135 | 2,748 | 3,144 |
Inventory | 1,999 | 1,749 | 2,209 | 2,280 | 2,440 | 3,072 |
Prepaid Expenses | - | 71.07 | 70.29 | 61.63 | 47.69 | 40.21 |
Other Current Assets | 3,165 | 1,123 | 315.43 | 207.49 | 300.4 | 345.15 |
Total Current Assets | 10,927 | 11,253 | 11,684 | 10,657 | 11,684 | 10,886 |
Property, Plant & Equipment | 5,133 | 5,341 | 5,550 | 5,885 | 6,246 | 6,511 |
Long-Term Investments | 428.7 | 1,233 | 1,316 | 1,431 | 376.22 | 370.77 |
Goodwill | 160.15 | 160.15 | 160.15 | 160.15 | 160.15 | 160.15 |
Other Intangible Assets | 762.78 | 759.99 | 591.29 | 511.18 | 517.08 | 549.09 |
Long-Term Deferred Tax Assets | 106.91 | 115.82 | 103.15 | 153.13 | 239.09 | 188.75 |
Long-Term Deferred Charges | 270.39 | 227.36 | 333.66 | 331.74 | 227.83 | 144.74 |
Other Long-Term Assets | 1,591 | 136.21 | 216.67 | 223.65 | 179.17 | 259.22 |
Total Assets | 19,381 | 19,227 | 19,956 | 19,352 | 19,630 | 19,070 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1,805 | 1,648 | 1,103 | 1,374 | 1,249 | 1,542 |
Accrued Expenses | 237.39 | 935.67 | 1,420 | 1,595 | 1,675 | 1,670 |
Short-Term Debt | - | - | 50.05 | 45.05 | 321.14 | 2,014 |
Current Portion of Long-Term Debt | - | - | 1,031 | - | 48.37 | 539.63 |
Current Portion of Leases | 7.24 | 8.85 | 8.86 | 10.6 | 9.86 | 40.13 |
Current Income Taxes Payable | 63.97 | 44.25 | 72.51 | 29.95 | 37.94 | 30.86 |
Current Unearned Revenue | 160.73 | 93.81 | 193.33 | 244.6 | 344.17 | 201.23 |
Other Current Liabilities | 936.97 | 403.65 | 465.17 | 480.59 | 509.97 | 804.25 |
Total Current Liabilities | 3,211 | 3,134 | 4,344 | 3,780 | 4,196 | 6,843 |
Long-Term Debt | - | - | - | 1,031 | 2,955 | 1,547 |
Long-Term Leases | 26.57 | 33.75 | 47.94 | 57.97 | 68.57 | 43 |
Long-Term Unearned Revenue | 77.87 | 83.49 | 113.99 | 122.8 | 138.01 | 140.33 |
Pension & Post-Retirement Benefits | 12.83 | 11.41 | 0.36 | 0.52 | 0.57 | 0.84 |
Long-Term Deferred Tax Liabilities | 65.41 | 62.5 | 70.77 | 22.15 | 119.55 | 126.19 |
Other Long-Term Liabilities | 56.96 | 56.96 | 56.96 | - | - | - |
Total Liabilities | 3,451 | 3,382 | 4,634 | 5,014 | 7,478 | 8,700 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1,341 | 1,341 | 1,341 | 1,341 | 1,172 | 1,027 |
Additional Paid-In Capital | 5,213 | 5,213 | 5,204 | 5,204 | 3,587 | 2,545 |
Retained Earnings | 7,201 | 7,226 | 6,660 | 5,845 | 5,287 | 4,762 |
Comprehensive Income & Other | -1.16 | -1.11 | -0.91 | -1.09 | 259.34 | 258.88 |
Total Common Equity | 13,754 | 13,779 | 13,204 | 12,388 | 10,305 | 8,593 |
Minority Interest | 2,175 | 2,066 | 2,118 | 1,950 | 1,847 | 1,777 |
Shareholders' Equity | 15,930 | 15,845 | 15,322 | 14,338 | 12,153 | 10,370 |
Total Liabilities & Equity | 19,381 | 19,227 | 19,956 | 19,352 | 19,630 | 19,070 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 33.82 | 42.6 | 1,138 | 1,145 | 3,403 | 4,184 |
Net Cash (Debt) | 4,105 | 7,018 | 6,505 | 4,828 | 2,745 | 99.84 |
Net Cash Growth | 0.29% | 7.89% | 34.74% | 75.89% | 2649.36% | - |
Net Cash Per Share | 3.06 | 5.23 | 4.85 | 3.79 | 2.37 | 0.08 |
Filing Date Shares Outstanding | 1,341 | 1,341 | 1,341 | 1,341 | 1,172 | 1,027 |
Total Common Shares Outstanding | 1,341 | 1,341 | 1,341 | 1,341 | 1,172 | 1,027 |
Working Capital | 7,716 | 8,119 | 7,340 | 6,877 | 7,489 | 4,044 |
Book Value Per Share | 10.26 | 10.27 | 9.85 | 9.24 | 8.57 | 8.11 |
Tangible Book Value | 12,832 | 12,859 | 12,452 | 11,717 | 9,628 | 7,884 |
Tangible Book Value Per Share | 9.57 | 9.59 | 9.28 | 8.74 | 7.99 | 7.42 |
Buildings | - | 4,385 | 4,491 | 4,472 | 3,945 | 3,874 |
Machinery | - | 8,525 | 8,453 | 8,370 | 8,184 | 7,920 |
Construction In Progress | - | 208.91 | 142.68 | 101.35 | 642.37 | 585.52 |